PTC Inc. ( (PTC) ) has released its Q4 earnings. Here is a breakdown of the information PTC Inc. presented to its investors. PTC Inc. is a ...

PTC Therapeutics ( (PTCT) ) has released its Q3 earnings. Here is a breakdown of the information PTC Therapeutics presented to its investors.

Fiscal '25 Constant Currency ARR Growth Guidance: 9% to 10%. PTC Inc (NASDAQ:PTC) reported a solid 25% year-over-year growth in free cash flow for fiscal 2024. The company achieved a 12% year-over ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy that ...

International Assets Investment Management LLC grew its stake in shares of PTC Inc. (NASDAQ:PTC – Free Report) by 786.5% during the third quarter, Holdings Channel reports. The institutional investor ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

The biopharmaceutical company posted revenue of $196.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $173.5 million. PTC Therapeutics expects full-year ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth-quarter conference call. (Operator Instructions) I would now like to turn the call over ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 Fourth Quarter Conference Call. During this presentation, all parties will be in a listen-only ...

Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrades for Pinterest, Editas Medicine, Gap, and Adobe, and a downgrade for PTC ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.